Hangzhou Sino-US Huadong Pharmaceutical

Huadong Medicine, through its core subsidiary Hangzhou Sino-US Huadong Pharmaceutical, is a leading Chinese pharmaceutical company specializing in the research, development, and commercialization of therapeutic products across endocrinology, oncology, immunology, and nephrology. The company has transitioned from a traditional manufacturer to an innovation-driven biotech player, notably through aggressive licensing deals and internal R&D in the GLP-1 and ADC spaces. Huadong is well-known for its dominant position in the Chinese diabetes market and its expanding global footprint in medical aesthetics. With a robust pipeline and established manufacturing capabilities, the company serves as a key partner for international firms looking to enter the Chinese healthcare market.